[go: up one dir, main page]

PE20060367A1 - Compuestos 8-azoniabiciclo[3.2.1]octanos como antagonistas del receptor de acetilcolina muscarinico - Google Patents

Compuestos 8-azoniabiciclo[3.2.1]octanos como antagonistas del receptor de acetilcolina muscarinico

Info

Publication number
PE20060367A1
PE20060367A1 PE2005000591A PE2005000591A PE20060367A1 PE 20060367 A1 PE20060367 A1 PE 20060367A1 PE 2005000591 A PE2005000591 A PE 2005000591A PE 2005000591 A PE2005000591 A PE 2005000591A PE 20060367 A1 PE20060367 A1 PE 20060367A1
Authority
PE
Peru
Prior art keywords
alkyl
cyane
compounds
bromide
azoniabicycle
Prior art date
Application number
PE2005000591A
Other languages
English (en)
Inventor
Jakob Busch-Petersen
Christopher E Neipp
Michael R Palovich
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PE20060367A1 publication Critical patent/PE20060367A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/16Central respiratory analeptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE ALCOHOL TERCIARIO DE 8-AZONIABICICLO[3.2.1]OCTANOS, DE FORMULA (I), EN DONDE R1 Y R2 SON INDEPENDIENTEMENTE H, ALQUILO(C1-C12), ALQUENILO(C2-C10), ALQUIL(C1-C6)CICLOALQUILO(C3-C6), ALQUIL(C1-C10)-ARILO, ALQUIL(C1-C10)-CN, ENTRE OTROS; R3 Y R4 SON INDEPENDIENTEMENTE ALQUILO(C1-C6) LINEAL O RAMIFICADO, CICLOALQUILO((C5-C6), CICLOALQUILALQUILO(C6-C10), 2-TIENILO, ARILO, HETEROERILO (C5-C6), CON HETEROETOMOS DE N U O; ENTRE OTROS; Y ES HIDROXI O CIANO; X- ES ANION ASOCIADO A UN N CON CARGA POSITIVA, TALES COMO CLORURO, BROMURO, YODURO, HIDROXI, SULFATO, ENTRE OTROS; LA CADENA LATERAL INDICADA PUEDE TENER ORIENTACION ENDO O EXO, PREFERENTEMENTE ENDO. SON PREFERIDOS: BROMURO DE 4-[CIANO(DI-2-TIENIL)METIL]-1-[3-(FENILOXI)PROPIL]-1-AZONIABICICLO[2.2.2]-OCTANO, BROMURO DE 4-[CIANO(DIFENIL)METIL]-1-[3-(FENILOXI)PROPIL]-1-AZONIABICICLO[2.2.2]-OCTANO, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA. ESTOS COMPUESTOS SON INHIBIDORES DE LOS RECEPTORES DE ACETILCOLINA MUSCARINICO (mAChR), POR LO QUE SON UTILES EN EL TRATAMIENTO DE ENFERMEDADES DEL TRACTO RESPIRATORIO COMO ENFERMEDAD OBSTRUCTIVA PULMONAR OBSTRUCTIVA CRONICA, FIBROSIS O EFISEMA PULMONAR Y RINITIS ALERGICA
PE2005000591A 2004-05-28 2005-05-26 Compuestos 8-azoniabiciclo[3.2.1]octanos como antagonistas del receptor de acetilcolina muscarinico PE20060367A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57532904P 2004-05-28 2004-05-28

Publications (1)

Publication Number Publication Date
PE20060367A1 true PE20060367A1 (es) 2006-04-28

Family

ID=35462875

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005000591A PE20060367A1 (es) 2004-05-28 2005-05-26 Compuestos 8-azoniabiciclo[3.2.1]octanos como antagonistas del receptor de acetilcolina muscarinico

Country Status (7)

Country Link
US (1) US7579345B2 (es)
EP (1) EP1749012A4 (es)
JP (1) JP2008501020A (es)
AR (1) AR048976A1 (es)
PE (1) PE20060367A1 (es)
TW (1) TW200606161A (es)
WO (1) WO2005118594A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200519108A (en) * 2003-07-17 2005-06-16 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
US7507747B2 (en) * 2003-10-17 2009-03-24 Glaxo Group Limited Muscarinic acetylcholine receptor antagonists
PE20050489A1 (es) * 2003-11-04 2005-09-02 Glaxo Group Ltd Antagonistas de receptores de acetilcolina muscarinicos
WO2005087236A1 (en) * 2004-03-11 2005-09-22 Glaxo Group Limited Novel m3 muscarinic acetylcholine receptor antagonists
US7384946B2 (en) * 2004-03-17 2008-06-10 Glaxo Group Limited M3 muscarinic acetylcholine receptor antagonists
TWI363759B (en) 2004-04-27 2012-05-11 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
WO2005112644A2 (en) * 2004-05-13 2005-12-01 Glaxo Group Limited Muscarinic acetylcholine receptor antagonists
JP2008520579A (ja) * 2004-11-15 2008-06-19 グラクソ グループ リミテッド 新規m3ムスカリン性アセチルコリン受容体アンタゴニスト
WO2007016639A2 (en) * 2005-08-02 2007-02-08 Glaxo Group Limited M3 muscarinic acetylcholine receptor antagonists
WO2007022351A2 (en) * 2005-08-18 2007-02-22 Glaxo Group Limited Muscarinic acetylcholine receptor antagonists
MX2009008527A (es) * 2007-02-23 2009-08-27 Theravance Inc Compuestos de amonio cuaternario y difenilmetilo utiles como antagonistas del receptor muscarinico.
PE20091563A1 (es) 2008-02-06 2009-11-05 Glaxo Group Ltd Farmacoforos duales - antagonistas muscarinicos de pde4
PE20091553A1 (es) 2008-02-06 2009-10-30 Glaxo Group Ltd Farmacoforos duales - antagonistas muscarinicos de pde4
TW201000476A (en) 2008-02-06 2010-01-01 Glaxo Group Ltd Dual pharmacophores-PDE4-muscarinic antagonistics
WO2010094643A1 (en) 2009-02-17 2010-08-26 Glaxo Group Limited Quinoline derivatives and their uses for rhinitis and urticaria

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476046B1 (en) * 2000-12-04 2002-11-05 Sepracor, Inc. Diazabicyclo[4.3.0]nonanes, and methods of use thereof
US6696462B2 (en) * 2002-01-31 2004-02-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions

Also Published As

Publication number Publication date
JP2008501020A (ja) 2008-01-17
AR048976A1 (es) 2006-06-14
US7579345B2 (en) 2009-08-25
EP1749012A1 (en) 2007-02-07
EP1749012A4 (en) 2009-07-29
TW200606161A (en) 2006-02-16
US20070232599A1 (en) 2007-10-04
WO2005118594A1 (en) 2005-12-15

Similar Documents

Publication Publication Date Title
PE20060367A1 (es) Compuestos 8-azoniabiciclo[3.2.1]octanos como antagonistas del receptor de acetilcolina muscarinico
PE20060259A1 (es) Compuestos de quinuclidina como antagonistas del receptor de acetilcolina muscarinico
PE20081837A1 (es) Derivados de quinuclinidol como antagonistas de los receptores muscarinicos
PE20050963A1 (es) Compuestos derivados de 8-azoniabiciclo [3.2.1]octanos como antagonistas de receptores de acetilcolina muscarinicos
PE20080361A1 (es) Compuestos derivados de purina como activadores del receptor de adenosina a2a
PE20091724A1 (es) Derivados de indol como moduladores del receptor nicotinico de acetilcolina alfa 7
PE20051051A1 (es) Compuestos de triazol como antagonistas de la vasopresina
PT100785A (pt) Utilizacao de compostos, por exemplo indole-3-carboxilatos, para a producao de medicamentos, compostos ai utilizados e composicoes farmaceuticas que os contem.
PE20080053A1 (es) Composiciones oftalmicas de alcaftadina
ES2314943T3 (es) Derivados de isoxazolo como agonistas inversos de gaba a alfa.
ES2277330T3 (es) Antagonistas del receptor 5-ht4.
PE20050489A1 (es) Antagonistas de receptores de acetilcolina muscarinicos
PE20051173A1 (es) Compuestos azabiciclico (3.1.0) hexanos como moduladores de receptores de dopamina d3
PE20081374A1 (es) Combinacion que comprende un agente antipsicotico y (2s)-(4e)-n-metil-5-[3-(5-isopropoxipiridin)il]-4-penten-2-amina
GT200500284A (es) Pirimidinas como antagonistas del receptor de prostaglandina d2
PE20081238A1 (es) Piperidinas sustituidas como antagonistas de hdm2
IL189191A0 (en) Thiazolyl piperidine derivatives useful as h3 receptor modulators
RU2000129161A (ru) Производное 1-[(1-замещенного-4-пиперидинил)метил]-4-пиперидина, способ его получения, фармацевтическая композиция, содержащая указанное соединение, и промежуточный продукт
DOP2006000046A (es) Derivados de oxindol
PE20080275A1 (es) Derivados de 5h-benzo[4,5]ciclohepta[1,2]piridina como inhibidores de tirosina quinasa
PT100854A (pt) Produtos farmaceuticos em especial derivados de quinolizidina ou de indolizidina, e processo para a sua preparacao e utilizacao
EA200970582A1 (ru) ПРОИЗВОДНЫЕ 5-[4-(АЗЕТИДИН-3-ИЛОКСИ)ФЕНИЛ]-2-ФЕНИЛ-5Н-ТИАЗОЛО[5,4-c]ПИРИДИН-4-ОНА И ИХ ИСПОЛЬЗОВАНИЕ В КАЧЕСТВЕ РЕЦЕПТОРОВ MCH
PE20040833A1 (es) Derivado de 1-aminociclohexano sustituidos en la posicion 4
ECSP067079A (es) Derivados de ácido carboxílico de bencimidazolona
AR072163A1 (es) Derivados de arilpirrolidinil y piperidinil-cetonas, composiciones farmaceuticas que los contienen, un metodo para el tratamiento o la prevencion de enfermedades y el uso del compuesto para la fabricacion de medicamentos

Legal Events

Date Code Title Description
FD Application declared void or lapsed